• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

介入性疼痛医学中的陷阱:一名患有血管性血友病的患者在接受硬膜外类固醇注射后使用去氨加压素导致低钠血症。

Pitfalls in Interventional Pain Medicine: Hyponatremia after DDAVP for a Patient with Von Willebrand Disease Undergoing an Epidural Steroid Injection.

作者信息

Khan Talal W, Yacoub Abdulraheem

机构信息

Department of Anesthesiology and Pain Medicine, University of Kansas Medical Center, Kansas City, KS, USA.

Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.

出版信息

Case Rep Anesthesiol. 2017;2017:6467090. doi: 10.1155/2017/6467090. Epub 2017 Mar 14.

DOI:10.1155/2017/6467090
PMID:28392945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5368395/
Abstract

Desmopressin (DDAVP), a synthetic analog of vasopressin, has been used in patients with von Willebrand disease (VWD), mild hemophilia A, and platelet dysfunction to reduce the risk of bleeding associated with surgical and interventional procedures. We report the case of a patient with VWD presenting with a bulging disc and radicular pain that underwent transforaminal epidural steroid injections. Her course was complicated with the interval development of headaches and dizziness symptomatic of moderate hyponatremia, likely due to excessive fluid intake. This report highlights a relatively rare side effect of DDAVP when used for prophylaxis in patients with VWD and reinforces the need for vigilance in these patients.

摘要

去氨加压素(DDAVP),一种血管加压素的合成类似物,已被用于治疗血管性血友病(VWD)、轻度甲型血友病和血小板功能障碍的患者,以降低与手术和介入操作相关的出血风险。我们报告了一例患有VWD的患者,该患者出现椎间盘突出和神经根性疼痛,并接受了经椎间孔硬膜外类固醇注射。她的病程因出现中度低钠血症症状的头痛和头晕而变得复杂,这可能是由于液体摄入过多所致。本报告强调了DDAVP在用于VWD患者预防时相对罕见的副作用,并强化了对这些患者保持警惕的必要性。

相似文献

1
Pitfalls in Interventional Pain Medicine: Hyponatremia after DDAVP for a Patient with Von Willebrand Disease Undergoing an Epidural Steroid Injection.介入性疼痛医学中的陷阱:一名患有血管性血友病的患者在接受硬膜外类固醇注射后使用去氨加压素导致低钠血症。
Case Rep Anesthesiol. 2017;2017:6467090. doi: 10.1155/2017/6467090. Epub 2017 Mar 14.
2
Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.皮下注射去氨加压素治疗遗传性出血性疾病患儿时特定液体限制方案的评估与验证
Haemophilia. 2016 Sep;22(5):700-5. doi: 10.1111/hae.12949. Epub 2016 Jul 6.
3
Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.去氨加压素:遗传性凝血障碍儿童和成人的治疗局限性
Br J Haematol. 2000 Jun;109(4):865-9. doi: 10.1046/j.1365-2141.2000.02067.x.
4
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.静脉注射去氨加压素和因子VIII-血管性血友病因子浓缩物用于治疗和预防1型、2型和3型血管性血友病患者的出血。
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.
5
Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).血友病和血管性血友病患者反复使用去氨加压素(DDAVP)后速发耐受性的发展模式。
Br J Haematol. 1992 Sep;82(1):87-93. doi: 10.1111/j.1365-2141.1992.tb04598.x.
6
Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries.去氨加压素(DDAVP)用于接受手术的出血性疾病儿科患者后出现的低钠血症。
J Pediatr Hematol Oncol. 2014 Aug;36(6):e371-5. doi: 10.1097/MPH.0000000000000185.
7
Experience of desmopressin (DDAVP) administration in patients with congenital and acquired bleeding disorders.先天性和获得性出血性疾病患者使用去氨加压素(DDAVP)的经验。
J Formos Med Assoc. 1992 Oct;91(10):962-9.
8
The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).去氨加压素在血管性血友病中的应用:头30年(1977 - 2007年)的经验
Haemophilia. 2008 Jan;14 Suppl 1:5-14. doi: 10.1111/j.1365-2516.2007.01610.x.
9
Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease.高浓度鼻内和静脉注射去氨加压素治疗轻度甲型血友病或轻度至中度1型血管性血友病患儿的疗效评估。
J Pediatr. 2002 May;140(5):595-9. doi: 10.1067/mpd.2002.123626.
10
Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.血管性血友病的特征、分类及治疗:文献与个人经验的批判性评估
Semin Thromb Hemost. 2005 Nov;31(5):577-601. doi: 10.1055/s-2005-922230.

引用本文的文献

1
Thoracic Radiofrequency Ablation in a Patient With Von Willebrand's Disease: A Case Report.一名血管性血友病患者的胸部射频消融术:病例报告
Cureus. 2024 Sep 24;16(9):e70102. doi: 10.7759/cureus.70102. eCollection 2024 Sep.

本文引用的文献

1
Perioperative incidence and management of hyponatremia in vWD patients undergoing adenotonsillectomy.围手术期 von Willebrand 病患者行腺样体扁桃体切除术时低钠血症的发生率及处理。
Laryngoscope. 2011 Jul;121(7):1399-403. doi: 10.1002/lary.21735. Epub 2011 Jun 6.
2
Considerations for epidural anesthesia in a patient with type 1 von Willebrand disease.考虑在 1 型血管性血友病患者中进行硬膜外麻醉。
J Anesth. 2009;23(4):597-600. doi: 10.1007/s00540-009-0782-z. Epub 2009 Nov 18.
3
Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses.患有常见出血性疾病的产科和非产科患者的神经轴技术。
Anesth Analg. 2009 Aug;109(2):648-60. doi: 10.1213/ane.0b013e3181ac13d1.
4
Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.2003年的血管性血友病:迈向全面鉴定基因缺陷以实现正确诊断和治疗
Haematologica. 2003 Jan;88(1):94-108.
5
Intranasal desmopressin-induced hyponatremia.鼻内去氨加压素诱导的低钠血症。
Pharmacotherapy. 1996 Jan-Feb;16(1):66-74.
6
Epidemiological investigation of the prevalence of von Willebrand's disease.血管性血友病患病率的流行病学调查
Blood. 1987 Feb;69(2):454-9.
7
Desmopressin (DDAVP) for treatment of disorders of hemostasis.去氨加压素(DDAVP)用于治疗止血障碍。
Prog Hemost Thromb. 1986;8:19-45.
8
Hyponatremia and seizures in young children given DDAVP.接受去氨加压素治疗的幼儿出现低钠血症和癫痫发作。
Am J Hematol. 1989 Jul;31(3):199-202. doi: 10.1002/ajh.2830310310.
9
Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs.血管活性药物作用后纤溶酶原激活物及凝血因子 VIII 增加的机制
Br J Haematol. 1975 May;30(1):81-93. doi: 10.1111/j.1365-2141.1975.tb00521.x.